Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
IRAK2 Biologics Sequence Review Report 2026: Interleukin-1 receptor-associated kinase-like 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of IRAK2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
LINGO1 Biologics Sequence Review Report 2026: Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of LINGO1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
LINGO2 Biologics Sequence Review Report 2026: Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of LINGO2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IRAK1 Biologics Sequence Review Report 2026: Interleukin-1 receptor-associated kinase 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of IRAK1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
HGFAC Biologics Sequence Review Report 2026: Hepatocyte growth factor activator serine protease Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of HGFAC protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
FCER1G Biologics Sequence Review Report 2026: High affinity immunoglobulin epsilon receptor subunit gamma Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of FCER1G protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
EPS15L1 Biologics Sequence Review Report 2026: Epidermal growth factor receptor substrate 15-like 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of EPS15L1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRG7 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G7 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRG7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
EPS15 Biologics Sequence Review Report 2026: Epidermal growth factor receptor substrate 15 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of EPS15 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
DNER Biologics Sequence Review Report 2026: Delta and Notch-like epidermal growth factor-related receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of DNER protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRL4 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRL4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRF2P Biologics Sequence Review Report 2026: Putative adhesion G protein-coupled receptor F2P Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRF2P protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.